BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nussbaum YI, Manjunath Y, Suvilesh KN, Warren WC, Shyu CR, Kaifi JT, Ciorba MA, Mitchem JB. Current and Prospective Methods for Assessing Anti-Tumor Immunity in Colorectal Cancer. Int J Mol Sci 2021;22:4802. [PMID: 33946558 DOI: 10.3390/ijms22094802] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Ge X, Xu M, Cheng T, Hu N, Sun P, Lu B, Wang Z, Li J. TP53I13 promotes metastasis in glioma via macrophages, neutrophils, and fibroblasts and is a potential prognostic biomarker. Front Immunol 2022;13:974346. [DOI: 10.3389/fimmu.2022.974346] [Reference Citation Analysis]
2 Song Y, Yu J, Li L, Wang L, Dong L, Xi G, Lu YJ, Li Z. Luteolin impacts deoxyribonucleic acid repair by modulating the mitogen-activated protein kinase pathway in colorectal cancer. Bioengineered 2022;13:10998-1011. [PMID: 35473479 DOI: 10.1080/21655979.2022.2066926] [Reference Citation Analysis]
3 Sun HY, Du ST, Li YY, Deng GT, Zeng FR. Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers. World J Gastrointest Oncol 2022; 14(1): 75-89 [DOI: 10.4251/wjgo.v14.i1.75] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Passardi A, Scarpi E, Ulivi P. Special Issue on Molecular and Translational Research on Colorectal Cancer 2.0. Int J Mol Sci 2021;22:7479. [PMID: 34299099 DOI: 10.3390/ijms22147479] [Reference Citation Analysis]